Ignite Creation Date:
2024-05-05 @ 4:46 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00314132
Status:
COMPLETED
Last Update Posted:
2012-12-06
First Post:
2006-04-11
Brief Title:
Safety Study of ChimeriVax-JE Vaccine to Prevent Japanese Encephalitis
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Randomised Double Blind Multicentre Placebo Controlled Phase III Study of the Safety and Tolerability Following Administration of Live Attenuated JE Vaccine ChimeriVax-JE
Status:
COMPLETED
Status Verified Date:
2012-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess whether ChimeriVax JE vaccine a new vaccine to be used for vaccination against Japanese encephalitis is safe and well tolerated when compared to placebo dummy vaccination
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None